Thilorbin eye drops

Replacement | Medicines | 17/12/2013

WABOSAN Arzneimittelvertriebs GmbH has informed its supplied customers by letter dated 12.12.2013 that yellow-orange precipitations have been observed in batch Y260 in individual cases and therefore a precautionary recall is being carried out. This medicinal product is approved in Germany and is placed on the market in Austria within the scope of a transfer notification pursuant to the Austrian Medicinal Products Import Act 2010.

Name of the medicinal product Thilorbin
Marketing authorisation number(s) DE-Zulassungsnummer: 6176696.00.00
Marketing authorisation holder OmniVision GmbH

Antragsteller Verbringungsmeldung:
WABOSAN Arzneimittelvertriebs GmbH
Batch number(s) Y260
Classification of the recall2
BASG reference number INS-640.001-0900
Email

Further inquiry note